Reading time: 3 minutes Colette Bilynsky A significant portion of my PhD research was related to colorectal cancer (CRC), so I had seen in the academic literature that the incidence rate of CRC was increasing for people under 50 years of age. Despite this, I was still surprised when on my social media I started... Continue Reading →
Reading time: 4 minutes Colette Bilynsky The wonders of cellular therapies and immunotherapies have been often discussed here on Oncobites. But one of the challenges here is that these strategies are dependent on immune cells' ability to reach tumors and still function. However, tumors will often try to evade and stop the immune system from... Continue Reading →
Reading time: 8 minutes Colette Bilynsky The number of people who will be diagnosed with cancer in their lifetime is growing, with estimates saying that by 2030, more than 26 million people worldwide will be affected by some type of cancer [1]. However, as noted throughout Oncobites, treatments are continually improving, resulting in increased patient... Continue Reading →
Reading time: 5 minutes Colette Bilynsky New treatment strategies are almost constantly being tested in pre-clinical research and clinical trials, with many of them outlined in various OncoBites articles. This is incredibly important work as groundbreaking treatment strategies like CAR-T therapy have the capacity to radically improve patient outcomes. CAR-T therapy takes the patient's own... Continue Reading →
Reading time: 5 minutes Colette Bilynsky The American Cancer Society has found colorectal cancer to be the 3rd highest cause of cancer deaths and 3rd highest estimated new cases in both men and women in 2022 [1]. The risk of colorectal cancer is significantly higher in people with inflammatory bowel disease (IBD): ulcerative colitis (UC),... Continue Reading →
Colette Bilynsky CAR-T cell therapy is widely available in the United States, with 6 FDA-approved formulations, and has been previously discussed on Oncobites. However, a new clinical trial using the CAR (chimeric antigen receptor) technology is underway, but using macrophages instead of T-Cells in the hope of treating more types of cancer. But let’s take... Continue Reading →
OncoBites 